P8IP
TNDM icon

Pier 88 Investment Partners’s Tandem Diabetes Care TNDM Stock Holding History

Pier 88 Investment Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,135
Closed -$204K – 119
2020
Q4 		$204K Hold
2,135
– – 0.07% 114
2020
Q3 		$242K Buy
2,135
+385
+22% +$40.5K 0.07% 103
2020
Q2 		$173K Sell
1,750
-8,520
-83% -$680K 0.05% 105
2020
Q1 		$661K Sell
10,270
-1,800
-15% -$126K 0.24% 64
2019
Q4 		$719K Buy
+12,070
New +$744K 0.28% 51

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Pier 88 Investment Partners's TNDM Position: Q1 2021 in Review

Pier 88 Investment Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2021, closing a stake of 2,135 shares — an estimated $204K sold.

Pier 88 Investment Partners first reported a position in TNDM in Q4 2019 and held it in 5 quarters. The position peaked at $719K in Q4 2019. 290 funds tracked by Wall St. Rank hold TNDM as of Q1 2021.

  • Pier 88 Investment Partners reported no remaining Tandem Diabetes Care position as of Q1 2021 after selling out during the quarter.
  • Pier 88 Investment Partners sold 2,135 Tandem Diabetes Care shares in Q1 2021, an estimated $204K.
  • Pier 88 Investment Partners first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 5 quarters.
  • Pier 88 Investment Partners's Tandem Diabetes Care position peaked at $719K in Q4 2019.
  • 290 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2021.

Based on Pier 88 Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.